Distal Access - Resectr Tissue Resection Device - Ownership and Business Overview

Medical ProductsCompany

Distal Access - Resectr Tissue Resection Device Ownership

Who owns Distal Access - Resectr Tissue Resection Device?

Distal Access - Resectr Tissue Resection Device is owned by Boston Scientific. It was acquired on November 15, 2016.

Distal Access - Resectr Tissue Resection Device Business Overview

Where is Distal Access - Resectr Tissue Resection Device headquartered?

Distal Access - Resectr Tissue Resection Device is headquartered in Salt Lake City, Utah.

What sector is Distal Access - Resectr Tissue Resection Device in?

Distal Access - Resectr Tissue Resection Device is a medical products company.

Medical Products M&A Summary in 2016

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2016. The largest medical products acquisition in 2016 was St. Jude Medical - which was acquired by Abbott Laboratories for $25.0B.

Join Mergr to view all 272 acquisitions of medical products companies in 2016, including 31 acquisitions by private equity firms, and 241 by strategics.

Distal Access LLC - Resectr Tissue Resection Device

Salt Lake City, Utah 84115
United States,

Distal Access LLC - Resectr Tissue Resection Device includes the Resectrâ„¢ Tissue Resection Device, a single-use solution designed to effectively remove uterine polyps.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.